GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumors.

Clemente, Valentino; Hoshino, Asumi; Shetty, Mihir; Nelson, Andrew; Erickson, Britt K; Baker, Ruth; Rubin, Nathan; Khalifa, Mahmoud; Weroha, S John; Lou, Emil; Bazzaro, Martina

Clemente, Valentino; Hoshino, Asumi; Shetty, Mihir; Nelson, Andrew; Erickson, Britt K; Baker, Ruth; Rubin, Nathan; Khalifa, Mahmoud; Weroha, S John; Lou, Emil; Bazzaro, Martina.

Afiliação

Clemente V; Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA.
Hoshino A; Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA.
Shetty M; Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA.
Nelson A; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Erickson BK; Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA.
Baker R; Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA.
Rubin N; Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Khalifa M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Weroha SJ; Departments of Oncology and Molecular Pharmacology, Mayo Clinic, Rochester, MN, USA.
Lou E; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Bazzaro M; Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA.

Cancer Res Commun ; 2(8): 784-794, 2022 08.

Article em En | MEDLINE | ID: mdl-36082022

Assuntos

Adenocarcinoma de Células Claras; Neoplasias Ovarianas; Animais; Feminino; Humanos; Camundongos; Adenocarcinoma de Células Claras/genética; Proteínas de Ligação a DNA/genética; Glutaminase/genética; Glutamina/metabolismo; Neoplasias Ovarianas/genética; Fatores de Proteção; Fatores de Transcrição/genética

Palavras-chave

ARID1A; CB839; GLS1; Glutaminase; Glutaminase inhibitor; Glutamine; OCCC

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Adenocarcinoma de Células Claras Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google